Biotechnology

Selecting the Right European Location for Life Sciences Activities

Agile and resilient: This is how manufacturers in the life sciences industry could be described during the Covid-19 pandemic. As disruption took hold in many other industries’ supply chains, life ­sciences companies moved to rapidly develop new products and build new capacity. They are maintaining this momentum, with pharmaceutical and biotech businesses showing continued interest in expanding existing operations in Europe or starting operations from scratch.

Swiss Biotech Report 2021

Switzerland, as one of the leading global biotech hubs, was well positioned to facilitate international collaborations and develop solutions to combat the Covid-19 pandemic, and the sector saw record levels of investment in 2020. This is the bottom line of the latest edition of the Swiss Biotech Report, published by the Swiss Biotech Association in conjunction with EY and eight other partner organizations.

Fujifilm Invests in Two US Facilities

Fujifilm Diosynth Biotechnologies, a subsidiary of Japan’s Fujifilm Corp., has announced plans to spend more than $2 billion to build a new large-scale cell culture production site in the US to accelerate the growth of its biopharma CDMO business.

Italian Biotech: A Vital and Dynamic Industry

The biotech industry in Italy is vital and is showing a constant growth, report by Assobiotec and ENEA documents.

Evonik Develops Fermentation-Based Platform for Animal-Free Collagen

Outsourcing Services: from Gene to Patient

Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient processes, Rentschler Biopharma is the preferred outsourcing partner for bioprocess development, cGMP manufacturing, as well as elaboration of product approval strategies for over 150 clients worldwide.

Innovative Chemistry Between Mountains and Lakes

Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan, as well as EU facilities in the United Kingdom and Germany. But do not underestimate the role of the domestic regional clusters and industrial sites.

Made in Switzerland – Exported Worldwide

Achieving Operational Excellence with a Digital Lab

With the cost pressures and time to market challenges that the health care industry faces, pharmaceutical and biotech companies must figure out ways to increase laboratory efficiency by managing its resources more effectively.

Injecting Growth and Innovation

Why CDMOs Should Consider Value-Based Pricing

The Importance of On-line Process Control

Live-Broadcasting of Bioprocesses

Biotechnological Production of Rare Functional Sugar

Biomade Peptides

Coupling Trends in Cultured Meat and Entomophagy

Boehringer Buys AMAL Therapeutics

Bionure Appoints Lucia Septien as Chief Medical Officer

Novartis Takes US Biotech IFM Tre

Pfizer Takes Stake in French Biotech Vivet

Roche Pays $4.3 Billion for Spark Therapeutics

Celgene Wins Patent Row, Gets Generic Rival

DuPont Breaks Ground for Dutch Bio-Site

Start-ups Accelerate Innovation

Virtually all areas of our lives would be inconceivable without products that come directly or indirectly in contact with chemical production: It affects the modern office environment, our private lives and thus our well-being and life fulfilment including health, leisure and personal protection.

CRB Expands Presence in Europe

Evolution of Technology

Innovative Anti-Infectives

If You Want to Go Far, Go Together

Supply Security of Non-cGMP Materials

Winning Strategies in the Pharmaceutical CDMO Industry

Kaneka Buys Spanish Biotech

Wacker Buys Dutch Biotechnology Plant

Hard Times for Bio-based Products

Biotechnology Is about to Change Our Lives

David Estapé to Join CRB Group as Technology Manager Biotechnology